Genetic Technologies (GTG) – StreetInsider.com Reports
-
Genetic Technologies (GTG) Files $75M Mixed Shelf
-
Genetic Technologies (GENE) Announces Ordinary Share Consolidation and ADS Ratio Change
-
Genetic Technologies (GTG) Granted Patent for COVID-19 Risk Test
-
Genetic Technologies (GENE) Provides Quarterly Business Update
-
Infinity BiologiX, Genetic Technologies (GENE) and Vault Heath launch new test to assess severity of COVID-19 in individuals
-
Genetic Technologies (GENE) appoints Mike Tonroe as CFO
-
Genetic Technologies (GENE) Provides Update on COVID-19 Risk Test Launch
-
Genetic Technologies (GTG) Signs Multi-Year US Distribution Agreement for COVID Risk Test
-
Genetic Technologies (GENE) Announces $6.56 Million Registered Direct Offering
-
Genetic Technologies (GENE) Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing
-
Genetic Technologies (GENE) Secures US and ANZ Distribution Rights for PREDICTIX
-
Genetic Technologies (GENE) Provides Update on COVID-19 Risk Test
-
Genetic Technologies (GTG) Provides Update on COVID-19 Disease Severity Test Development
-
Genetic Technologies (GENE) Regains Compliance with Nasdaq Stockholders Equity Requirement
-
Genetic Technologies (GENE) Announces $5.1 Million Registered Direct Offering of ADSs
-
Genetic Technologies (GTG) Provides Update on COVID-19 Disease Severity Test
-
Genetic Technologies (GTG) Announces US Patent Office Grants Key Risk Test Patent
-
Genetic Technologies (GENE) Announces Pricing of $8 Million Public Offering of ADSs
-
Genetic Technologies (GTG) Provides Operational Update
-
Genetic Technologies (GENE) Announces $1.8 Million Registered Direct Offering of ADSs
-
Genetic Technologies (GENE) Receives Nasdaq Notification Letter
-
Genetic Technologies (GENE) Enters Agreement, Will Receive $200K From Project Shivom
-
Genetic Technologies (GTG) Reports Strategic Alliance and Capital Raising
-
Genetic Technologies (GTG) Provides Update on Strategic Alliance
-
Genetic Technologies (GENE) Says it Regained Nasdaq Listing Compliance
-
Genetic Technologies (GENE) Changes Pricing and Billing structure for BREVAGenplus
-
Genetic Technologies (GENE) Appoints New Senior Medical Director
-
Genetic Technologies (GENE) Announces Publication of BREVAGenplus Data in Certain Women
Back to GTG Stock Lookup